Induction of UGT1A1 was one of the underlying mechanisms of treatment with phenobarbital, a CAR agonist used as a standard treatment for neonatal hyperbilirubinemia before the introduction of phototherapy39,40 and used in Crigler-Najjar syndrome type 241. Here, UGT1A1 is linked to Hyperbilirubinemia.